Key facts
- This page summarizes Boxer Capital, LLC's Form 4/A - Amendment filing for Tango Therapeutics, Inc. (TNGX).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 11 Oct 2023, 19:22.
Key filing fact
Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Award
No transaction description listed
No transaction description listed
No transaction description listed
No transaction description listed
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Award
Additional SEC filing notes
Footnote F1
These securities are owned directly by MVA Investors, LLC ("MVA Investors"). Aaron I. Davis is a member of and has voting and dispositive power over securities held by MVA Investors. Each reporting person other than MVA Investors disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any.
Footnote F2
These securities are owned directly by Boxer Capital, LLC ("Boxer Capital"). Boxer Asset Management Inc. is the managing member of Boxer Capital. Joseph Lewis is the sole indirect owner of Boxer Asset Management Inc. Mr. Davis is a member of Boxer Capital. Each reporting person other than Boxer Capital disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any.
Footnote F3
These securities are owned directly by Mr. Davis. Each reporting person other than Mr. Davis disclaims beneficial ownership of these securities.
Footnote F4
These securities are owned directly by Braslyn Ltd. Mr. Lewis is the sole indirect owner of Braslyn Ltd. Each reporting person other than Mr. Lewis disclaims beneficial ownership of these securities.
Footnote F5
These securities are owned directly by BCTG Holdings, LLC ("BCTG"). Boxer Capital is the majority member of BCTG and MVA Investors is a member of BCTG. Mr. Davis is an investment manager of BCTG. Each reporting person disclaims beneficial ownership of these securities except to the extent of such person's pecuniary interest therein, if any.
Footnote F6
The prefunded warrants have an exercise price of $0.001 per share of Common Stock and are immediately exercisable and remain exercisable until exercised in full, subject to a 9.99% beneficial ownership limitation which may be increased or decreased by the holder upon 61 days' notice to the Issuer.
SEC remarks
This amended Form 4, which amends and restates in its entirety the original Form 4 filed on August 15, 2023, corrects the transaction codes in the original filing. These acquisitions were made in transactions with the Company under Rule 16b-3, as opposed to open market purchases. The reporting persons may be deemed members of a group that beneficially owns more than 10% of the outstanding shares of common stock, $0.001 par value per share, of Tango Therapeutics, Inc. (the "Issuer"). At the time of the transactions reported herein, Mr. Davis was a director of the Issuer and the other reporting persons were subject to Section 16 as directors of the Issuer on the basis of their relationships to Mr. Davis.